Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pharmacotherapy
100%
Attention Deficit Hyperactivity Disorder
100%
Cost Analysis
100%
Expected Cost
100%
Immediate Release
66%
Total Expected Cost
66%
Adderall
66%
Methylphenidate
50%
Meta-analysis
33%
Clinical Assessment
33%
Extended Release
33%
Concerta
33%
Ritalin
33%
Patient Management
16%
Hyperactivity
16%
Clinical Management
16%
Treatment Regimen
16%
Response Rate
16%
Clinical Characteristics
16%
Cognitive Outcome
16%
Behavioral Outcomes
16%
Care Pathway
16%
Prevalence Estimates
16%
Twice Daily
16%
Elementary School children
16%
Impulsivity
16%
Survey Instrument
16%
Decision-analytic Model
16%
Children with Attention Deficit
16%
School-age children
16%
Neurobehavioral Disorders
16%
Dextroamphetamine
16%
Psychostimulant Medication
16%
Review Assessment
16%
Extended-release Methylphenidate
16%
Drug Acquisition Cost
16%
Patient Journey
16%
Amphetamine Salts
16%
Medicine and Dentistry
Drug Therapy
100%
Cost Benefit Analysis
100%
Attention Deficit Disorder
100%
Methylphenidate
100%
Health Care Cost
50%
Adderall
33%
Meta-Analysis
16%
Clinical Assessment
16%
Prevalence
8%
Clinical Management
8%
Hyperactivity
8%
Impulsiveness
8%
Psychostimulant
8%
Dextroamphetamine
8%
School-Age Children
8%
Diseases
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Attention Deficit Disorder
100%
Methylphenidate
100%
Amphetamine Plus Dexamphetamine
33%
Prevalence
8%
Psychostimulant
8%
Hyperactivity
8%
Dexamphetamine
8%
Diseases
8%
Amphetamine
8%